1 Einleitung
6.3 Abkürzungsverzeichnis
ACSF artifizielle zerebrospinale Flüssigkeit CDKL5-Gen cyclin-dependent kinase-like-5-Gen
CN (Natrium-)Cyanid
DMSO Dimethylsulfoxid
FCCP Carbonylcyanid-4-(trifluoromethoxy)phenylhydrazon FWHM full width of half maximum (Halbwertsbreite)
HBSS Hanks balanced salt solution
IR infrarot
JC-1
5,5',6,6'-Tetrachloro-1,1',3,3'-Tetraethylbenzimidazolylcarbocyanine Iodid
KO knockout
MeCP2 methyl CpG binding protein 2, vom MECP2-Gen kodiertes Protein
Mecp2-/y Maus-Modell des Rett-Syndroms, MeCP2-Maus, männliches Tier
NA numerische Apertur
OMC Oligomycin
PSF point spread function ROS reaktive Sauerstoffspezies
TPLSM 2-Photonen-Laser-Scanning-Mikroskop
VIS visible
WT Wildtyp
λ Wellenlänge
Literaturverzeichnis
7 Literaturverzeichnis
Amir RE, van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY (1999): Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23, 185–188
Armstrong DD (2005): Neuropathology of Rett syndrome. J Child Neurol 20, 747–753 Ballas N, Lioy DT, Grunseich C, Mandel G (2009): Non-cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology. Nat Neurosci 12, 311–317 Banerjee A, Castro J, Sur M (2012): Rett syndrome: genes, synapses, circuits, and therapeutics. Front Psychiatry 3, 34
Belichenko PV, Wright EE, Belichenko NP, Masliah E, Li HH, Mobley WC, Francke U (2009): Widespread changes in dendritic and axonal morphology in Mecp2-mutant mouse models of Rett syndrome: evidence for disruption of neuronal networks. J Comp Neurol 514, 240–258
Bereiter-Hahn J, Voth M (1994): Dynamics of mitochondria in living cells: shape changes, dislocations, fusion, and fission of mitochondria. Microsc Res Tech 27, 198–
219
Cadenas E (1989): Biochemistry of oxygen toxicity. Annu Rev Biochem 58, 79–110 Castro J, Garcia RI, Kwok S, Banerjee A, Petravicz J, Woodson J, Mellios N, Tropea D, Sur M (2014): Functional recovery with recombinant human IGF1 treatment in a mouse model of Rett Syndrome. Proc Natl Acad Sci U S A 111, 9941–9946
Cereghetti GM, Costa V, Scorrano L (2010): Inhibition of Drp1-dependent
mitochondrial fragmentation and apoptosis by a polypeptide antagonist of calcineurin.
Cell Death Differ 17, 1785–1794
Chahrour M, Zoghbi HY (2007): The story of Rett syndrome: from clinic to neurobiology. Neuron 56, 422–437
Chahrour M, Jung SY, Shaw C, Zhou X, Wong STC, Qin J, Zoghbi HY (2008):
MeCP2, a Key Contributor to Neurological Disease, Activates and Represses Transcription. Science (New York, N.Y.) 320, 1224–1229
Chapleau CA, Lane J, Larimore J, Li W, Pozzo-Miller L, Percy A (2013): Recent progress in Rett syndrome and MECP2 dysfunction: assessment of potential treatment options. Future Neurol 8, 21–28
Chen RZ, Akbarian S, Tudor M, Jaenisch R (2001): Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat Genet 27, 327–331
Coker SB, Melnyk AR (1991): Rett syndrome and mitochondrial enzyme deficiencies.
J Child Neurol 6, 164–166
Collins TJ, Bootman MD (2003): Mitochondria are morphologically heterogeneous within cells. J Exp Biol 206, 1993–2000
Cornford ME, Philippart M, Jacobs B, Scheibel AB, Vinters HV (1994):
Neuropathology of Rett syndrome: case report with neuronal and mitochondrial abnormalities in the brain. J Child Neurol 9, 424–431
Cossarizza A, Baccarani-Contri M, Kalashnikova G, Franceschi C (1993): A new method for the cytofluorimetric analysis of mitochondrial membrane potential using
Literaturverzeichnis
the J-aggregate forming lipophilic cation
5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolcarbocyanine iodide (JC-1). Biochem Biophys Res Commun 197, 40–45
Cotton NP, Clark AJ, Jackson JB (1981): The effect of venturicidin on light and oxygen-dependent electron transport, proton translocation, membrane potential development and ATP synthesis in intact cells of Rhodopseudomonas capsulata Arch Microbiol. 129, 94–99
Dedov VN, Cox GC, Roufogalis BD (2001): Visualisation of mitochondria in living neurons with single- and two-photon fluorescence laser microscopy. Micron 32, 653–
660
Denk W, Strickler JH, Webb WW (1990): Two-photon laser scanning fluorescence microscopy. Science 248, 73–76
Derecki NC, Cronk JC, Lu Z, Xu E, Abbott SBG, Guyenet PG, Kipnis J (2012): Wild-type microglia arrest pathology in a mouse model of Rett syndrome. Nature 484, 105–
109
Diaspro A, Bianchini P, Vicidomini G, Faretta M, Ramoino P, Usai C (2006): Multi-photon excitation microscopy. Biomed Eng Online 5, 36
Dotti MT, Manneschi L, Malandrini A, Stefano N de, Caznerale F, Federico A (1993):
Mitochondrial dysfunction in Rett syndrome. An ultrastructural and biochemical study. Brain Dev 15, 103–106
Dragich J, Houwink-Manville I, Schanen C (2000): Rett syndrome: a surprising result of mutation in MECP2. Hum Mol Genet 9, 2365–2375
Duchen MR, Surin A, Jacobson J (2003): Imaging mitochondrial function in intact cells. Methods Enzymol 361, 353–389
Eeg-Olofsson O, al-Zuhair AG, Teebi AS, al-Essa MM (1988): Abnormal mitochondria in the Rett syndrome. Brain Dev 10, 260–262
Egger J, Hofacker N, Schiel W, Holthausen H (1992): Magnesium for hyperventilation in Rett's syndrome. Lancet 340, 621–622
Ellaway CJ, Peat J, Williams K, Leonard H, Christodoulou J (2001): Medium-term open label trial of L-carnitine in Rett syndrome. Brain Dev 23 Suppl 1, S85-9 Felice C de, Signorini C, Leoncini S, Pecorelli A, Durand T, Valacchi G, Ciccoli L, Hayek J (2012): The role of oxidative stress in Rett syndrome: an overview. Ann N Y Acad Sci 1259, 121–135
Filosa S, Pecorelli A, DEspositoc M, Valacchi G, Hajek J (2015): Exploring the possible link between MeCP2 and oxidative stress in Rett syndrome. Free Radic Biol Med 88, 81–90
Fischer M, Reuter J, Gerich FJ, Hildebrandt B, Hagele S, Katschinski D, Müller M (2009): Enhanced hypoxia susceptibility in hippocampal slices from a mouse model of rett syndrome. J Neurophysiol 101, 1016–1032
Forlani G, Giarda E, Ala U, Di Cunto F, Salani M, Tupler R, Kilstrup-Nielsen C, Landsberger N (2010): The MeCP2/YY1 interaction regulates ANT1 expression at 4q35: novel hints for Rett syndrome pathogenesis. Hum Mol Genet 19, 3114–3123 Formichi P, Battisti C, Dotti MT, Hayek G, Zappella M, Federico A (1998): Vitamin E serum levels in Rett syndrome. J Neurol Sci 156, 227–230
Literaturverzeichnis
Foster KA, Galeffi F, Gerich FJ, Turner DA, Müller M (2006): Optical and
pharmacological tools to investigate the role of mitochondria during oxidative stress and neurodegeneration. Prog Neurobiol 79, 136–171
Gibson JH, Slobedman B, K N H, Williamson SL, Minchenko D, El-Osta A, Stern JL, Christodoulou J (2010): Downstream targets of methyl CpG binding protein 2 and their abnormal expression in the frontal cortex of the human Rett syndrome brain.
BMC Neurosci 11, 53
Gill H, Cheadle JP, Maynard J, Fleming N, Whatley S, Cranston T, Thompson EM, Leonard H, Davis M, Christodoulou J et al. (2003): Mutation analysis in the MECP2 gene and genetic counselling for Rett syndrome. J Med Genet 40, 380–384
Gold WA, Williamson SL, Kaur S, Hargreaves IP, Land JM, Pelka GJ, Tam PPL, Christodoulou J (2014): Mitochondrial dysfunction in the skeletal muscle of a mouse model of Rett syndrome (RTT): implications for the disease phenotype.
Mitochondrion 15, 10–17
Göppert-Mayer M (1931): Über Elementarakte mit zwei Quantensprüngen. Ann. Phys 9, 273–294
Grosser E, Hirt U, Janc OA, Menzfeld C, Fischer M, Kempkes B, Vogelgesang S, Manzke TU, Opitz L, Salinas-Riester G et al. (2012): Oxidative burden and mitochondrial dysfunction in a mouse model of Rett syndrome. Neurobiol Dis 48, 102–114
Guy J, Hendrich B, Holmes M, Martin JE, Bird A (2001): A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet 27, 322–326
Hagberg B (1985): Rett syndrome: Swedish approach to analysis of prevalence and cause. Brain Dev 7, 276–280
Hagberg B, Witt-Engerstrom I (1986): Rett syndrome: a suggested staging system for describing impairment profile with increasing age towards adolescence. Am J Med Genet Suppl 1, 47–59
Hagberg B, Aicardi J, Dias K, Ramos O (1983): A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases. Ann Neurol 14, 471–479
Hagberg B, Berg M, Steffenburg U (2001): Three decades of sociomedical
experiences from West Swedish Rett females 4-60 years of age. Brain Dev 23 Suppl 1, S28-31
Hamad I, Arda N, Pekmez M, Karaer S, Temizkan G (2010): Intracellular scavenging activity of Trolox (6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid) in the fission yeast, Schizosaccharomyces pombe. J Nat Sci Biol Med 1, 16–21
Hirt U: Extramitochondriale und mitochondriale Produktion reaktiver Sauerstoff-spezies im Hippocampus MeCP2-defizienter Mäuse. Med. Diss. Göttingen 2014 Janc OA: Pharmacotreatment of a mouse model of Rett syndrome with the radical scavenger Trolox: Detailed assessment of potential merits in vitro and in vivo.
Naturwissenschaftl. Diss. Göttingen 2015
Janc OA, Müller M (2014): The free radical scavenger Trolox dampens neuronal hyperexcitability, reinstates synaptic plasticity, and improves hypoxia tolerance in a mouse model of Rett syndrome. Front Cell Neurosci 8, 56
Literaturverzeichnis
Johnson CM, Cui N, Zhong W, Oginsky MF, Jiang C (2015): Breathing abnormalities in a female mouse model of Rett syndrome. J Physiol Sci 65, 451–459
Katz DM, Dutschmann M, Ramirez J, Hilaire G (2009): Breathing disorders in Rett syndrome: progressive neurochemical dysfunction in the respiratory network after birth. Respir Physiol Neurobiol 168, 101–108
Keil VC, Funke F, Zeug A, Schild D, Müller M (2011): Ratiometric high-resolution imaging of JC-1 fluorescence reveals the subcellular heterogeneity of astrocytic mitochondria. Pflügers Arch 462, 693–708
Kerr AM, Armstrong DD, Prescott RJ, Doyle D, Kearney DL (1997): Rett syndrome:
analysis of deaths in the British survey. Eur Child Adolesc Psychiatry 6 Suppl 1, 71–
74
Khwaja OS, Ho E, Barnes KV, O'Leary HM, Pereira LM, Finkelstein Y, Nelson CA3, Vogel-Farley V, DeGregorio G, Holm IA et al. (2014): Safety, pharmacokinetics, and preliminary assessment of efficacy of mecasermin (recombinant human IGF-1) for the treatment of Rett syndrome. Proc Natl Acad Sci U S A 111, 4596–4601
Kriaucionis S, Paterson A, Curtis J, Guy J, Macleod N, Bird A (2006): Gene expression analysis exposes mitochondrial abnormalities in a mouse model of Rett syndrome. Mol Cell Biol 26, 5033–5042
Kron M, Zimmermann JL, Dutschmann M, Funke F, Müller M (2011): Altered responses of MeCP2-deficient mouse brain stem to severe hypoxia. J Neurophysiol 105, 3067–3079
Kurtz R, Fricke M, Kalb J, Tinnefeld P, Sauer M (2006): Application of multiline two-photon microscopy to functional in vivo imaging. J Neurosci Methods 151, 276–286 Landi S, Putignano E, Boggio EM, Giustetto M, Pizzorusso T, Ratto GM (2011): The short-time structural plasticity of dendritic spines is altered in a model of Rett
syndrome. Sci Rep 1, 45
Legros F, Lombes A, Frachon P, Rojo M (2002): Mitochondrial fusion in human cells is efficient, requires the inner membrane potential, and is mediated by mitofusins. Mol Biol Cell 13, 4343–4354
Li Y, Wang H, Muffat J, Cheng AW, Orlando DA, Loven J, Kwok S, Feldman DA, Bateup HS, Gao Q et al. (2013): Global transcriptional and translational repression in human-embryonic-stem-cell-derived Rett syndrome neurons. Cell Stem Cell 13, 446–
458
Lioy DT, Garg SK, Monaghan CE, Raber J, Foust KD, Kaspar BK, Hirrlinger PG, Kirchhoff F, Bissonnette JM, Ballas N et al. (2011): A role for glia in the progression of Rett's syndrome. Nature 475, 497–500
Lobsiger CS, Cleveland DW (2007): Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease. Nat Neurosci 10, 1355–1360
Lotan M (2007): Alternative therapeutic intervention for individuals with Rett syndrome. ScientificWorldJournal 7, 698–714
Maezawa I, Jin L (2010): Rett syndrome microglia damage dendrites and synapses by the elevated release of glutamate. J Neurosci 30, 5346–5356
Maffei S, Felice C de, Cannarile P, Leoncini S, Signorini C, Pecorelli A, Montomoli B, Lunghetti S, Ciccoli L, Durand T et al. (2014): Effects of omega-3 PUFAs
Literaturverzeichnis
supplementation on myocardial function and oxidative stress markers in typical Rett syndrome. Mediators Inflamm 2014, 983178
Mak SC, Chi CS, Chen CH, Shian WJ (1993): Abnormal mitochondria in Rett syndrome: one case report. Zhonghua Yi Xue Za Zhi (Taipei) 52, 116–119
Mari F, Azimonti S, Bertani I, Bolognese F, Colombo E, Caselli R, Scala E, Longo I, Grosso S, Pescucci C et al. (2005): CDKL5 belongs to the same molecular pathway of MeCP2 and it is responsible for the early-onset seizure variant of Rett syndrome. Hum Mol Genet 14, 1935–1946
Mathur A, Hong Y, Kemp BK, Barrientos AA, Erusalimsky JD (2000): Evaluation of fluorescent dyes for the detection of mitochondrial membrane potential changes in cultured cardiomyocytes. Cardiovasc Res 46, 126–138
Matsuishi T, Urabe F, Percy AK, Komori H, Yamashita Y, Schultz RS, Ohtani Y, Kuriya N, Kato H (1994): Abnormal carbohydrate metabolism in cerebrospinal fluid in Rett syndrome. J Child Neurol 9, 26–30
McArthur AJ, Budden SS (1998): Sleep dysfunction in Rett syndrome: a trial of exogenous melatonin treatment. Dev Med Child Neurol 40, 186–192
McBride HM, Neuspiel M, Wasiak S (2006): Mitochondria: more than just a powerhouse. Curr Biol 16, R551-60
Menzfeld C, Janc OA, Dudek J, Rehling P, Müller M (2014): Mitochondrial dysfunction in Rett syndrome viewed from the biochemical perspective. 13th Rett Syndrome Symposium, Chantilly, VA, abstract, 78
Mitchell P (1961): Coupling of phosphorylation to electron and hydrogen transfer by a chemi-osmotic type of mechanism. Nature 191, 144–148
Mitchell P (1979): Keilin's respiratory chain concept and its chemiosmotic consequences. Science 206, 1148–1159
Monteiro CB, Savelsbergh GJ, Smorenburg AR, Graciani Z, Torriani-Pasin C, Abreu LC de, Valenti VE, Kok F (2014): Quantification of functional abilities in Rett syndrome: a comparison between stages III and IV. Neuropsychiatr Dis Treat 10, 1213–1222
Moretti P, Levenson JM, Battaglia F, Atkinson R, Teague R, Antalffy B, Armstrong D, Arancio O, Sweatt JD, Zoghbi HY (2006): Learning and memory and synaptic plasticity are impaired in a mouse model of Rett syndrome. J Neurosci 26, 319–327 Mount RH, Hastings RP, Reilly S, Cass H, Charman T (2001): Behavioural and emotional features in Rett syndrome. Disabil Rehabil 23, 129–138
Müller M, Can K (2014): Aberrant redox homoeostasis and mitochondrial dysfunction in Rett syndrome. Biochem Soc Trans 42, 959–964
Müller M, Schmidt J, Mironov SL, Richter DW (2003): Construction and performance of a custom-built two-photon laser scanning system. J. Phys. D: Appl. Phys. 36, 1747–
1757
Nasse MJ, Woehl JC, Huant S (2007): High-resolution mapping of the
three-dimensional point spread function in the near-focus region of a confocal microscope.
Appl. Phys. Lett. 90, 31106
Nguyen MVC, Du F, Felice CA, Shan X, Nigam A, Mandel G, Robinson JK, Ballas N (2012): MeCP2 is critical for maintaining mature neuronal networks and global brain
Literaturverzeichnis
anatomy during late stages of postnatal brain development and in the mature adult brain. J Neurosci 32, 10021–10034
Nguyen MVC, Felice CA, Du F, Covey MV, Robinson JK, Mandel G, Ballas N (2013): Oligodendrocyte lineage cells contribute unique features to Rett syndrome neuropathology. J Neurosci 33, 18764–18774
Nomura Y, Segawa M (2005): Natural history of Rett syndrome. J Child Neurol 20, 764–768
Ormazabal A, Artuch R, Vilaseca MA, Aracil A, Pineda M (2005): Cerebrospinal fluid concentrations of folate, biogenic amines and pterins in Rett syndrome: treatment with folinic acid. Neuropediatrics 36, 380–385
Percy AK, Glaze DG, Schultz RJ, Zoghbi HY, Williamson D, Frost JD, JR, Jankovic JJ, del Junco D, Skender M, Waring S (1994): Rett syndrome: controlled study of an oral opiate antagonist, naltrexone. Ann Neurol 35, 464–470
Perry SW, Norman JP, Barbieri J, Brown EB, Gelbard HA (2011): Mitochondrial membrane potential probes and the proton gradient: a practical usage guide.
Biotechniques 50, 98–115
Poot M, Zhang YZ, Kramer JA, Wells KS, Jones LJ, Hanzel DK, Lugade AG, Singer VL, Haugland RP (1996): Analysis of mitochondrial morphology and function with novel fixable fluorescent stains. J Histochem Cytochem 44, 1363–1372
Reers M, Smith TW, Chen LB (1991): J-aggregate formation of a carbocyanine as a quantitative fluorescent indicator of membrane potential. Biochemistry 30, 4480–4486 Reers M, Smiley ST, Mottola-Hartshorn C, Chen A, Lin M, Chen LB (1995):
Mitochondrial membrane potential monitored by JC-1 dye. Methods Enzymol 260, 406–417
Rett A (1966): Über ein eigenartiges hirnatrophisches Syndrom bei Hyperammonämie im Kindesalter. Wien Med Wochenschr 116, 723–726
Ruch A, Kurczynski TW, Velasco ME (1989): Mitochondrial alterations in Rett syndrome. Pediatr Neurol 5, 320–323
Salvioli S, Ardizzoni A, Franceschi C, Cossarizza A (1997): JC-1, but not DiOC6(3) or rhodamine 123, is a reliable fluorescent probe to assess ∆Y changes in intact cells:
implications for studies on mitochondrial functionality during apoptosis. FEBS Lett 411, 77–82
Sanmann JN, Schaefer GB, Buehler BA, Sanger WG (2012): Algorithmic approach for methyl-CpG binding protein 2 (MECP2) gene testing in patients with
neurodevelopmental disabilities. J Child Neurol 27, 346–354
Saywell V, Viola A, Confort-Gouny S, Le Fur Y, Villard L, Cozzone PJ (2006): Brain magnetic resonance study of Mecp2 deletion effects on anatomy and metabolism.
Biochem Biophys Res Commun 340, 776–783
Shetty PK, Galeffi F, Turner DA (2012): Cellular Links between Neuronal Activity and Energy Homeostasis. Front Pharmacol 3, 43
Sierra C, Vilaseca MA, Brandi N, Artuch R, Mira A, Nieto M, Pineda M (2001):
Oxidative stress in Rett syndrome. Brain Dev 23 Suppl 1, S236-9
Signorini C, Felice C de, Leoncini S, Durand T, Galano J, Cortelazzo A, Zollo G, Guerranti R, Gonnelli S, Caffarelli C et al. (2014): Altered erythrocyte membrane fatty
Literaturverzeichnis
acid profile in typical Rett syndrome: Effects of omega-3 polyunsaturated fatty acid supplementation. Prostaglandins Leukot Essent Fatty Acids 91, 183–193
Sims PJ, Waggoner AS, Wang CH, Hoffman JF (1974): Studies on the mechanism by which cyanine dyes measure membrane potential in red blood cells and
phosphatidylcholine vesicles. Biochemistry 13, 3315–3330
Smiley ST, Reers M, Mottola-Hartshorn C, Lin M, Chen A, Smith TW, Steele GD, JR., Chen LB (1991): Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1. Proc Natl Acad Sci U S A 88, 3671–3675
Stettner GM, Huppke P, Brendel C, Richter DW, Gärtner J, Dutschmann M (2007):
Breathing dysfunctions associated with impaired control of postinspiratory activity in Mecp2-/y knockout mice. J Physiol 579, 863–876
Suen D, Norris KL, Youle RJ (2008): Mitochondrial dynamics and apoptosis. Genes Dev 22, 1577–1590
Trappe R, Laccone F, Cobilanschi J, Meins M, Huppke P, Hanefeld F, Engel W (2001): MECP2 mutations in sporadic cases of Rett syndrome are almost exclusively of paternal origin. Am J Hum Genet 68, 1093–1101
Tropea D, Giacometti E, Wilson NR, Beard C, McCurry C, Fu DD, Flannery R, Jaenisch R, Sur M (2009): Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice. Proc Natl Acad Sci U S A 106, 2029–2034
Valenti D, Bari L de, Filippis B de, Henrion-Caude A, Vacca RA (2014):
Mitochondrial dysfunction as a central actor in intellectual disability-related diseases:
an overview of Down syndrome, autism, Fragile X and Rett syndrome. Neurosci Biobehav Rev 46 Pt 2, 202–217
Villard L (2007): MECP2 mutations in males. J Med Genet 44, 417–423
Weaving LS, Christodoulou J, Williamson SL, Friend KL, McKenzie OLD, Archer H, Evans J, Clarke A, Pelka GJ, Tam PPL et al. (2004): Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation. Am J Hum Genet 75, 1079–1093
Weaving LS, Ellaway CJ, Gecz J, Christodoulou J (2005): Rett syndrome: clinical review and genetic update. J Med Genet 42, 1–7
Williamson SL, Christodoulou J (2006): Rett syndrome: new clinical and molecular insights. Eur J Hum Genet 14, 896–903
Internetquellen
Danksagung
Danksagung
Ich danke Herrn Prof. Dr. rer. nat. Michael Müller für die interessante Aufgabenstellung und kompetente Betreuung während meiner Promotionsphase. Er stand mir stets mit Rat und Tat zur Seite und war jederzeit bei Fragen und Problemen ein geduldiger Ansprechpartner.
Weiterhin danke ich meinen Kollegen aus der Arbeitsgruppe Müller für jeden weiteren unterstützenden Beitrag. Auch möchte ich Belinda Kempkes für ihre Einführung in Material und Methoden dieser Arbeit danken.